Total submissions: 7
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Centre for Mendelian Genomics, |
RCV000414777 | SCV000493024 | likely pathogenic | Global developmental delay; Seizure; Delayed speech and language development; Microcephaly; Delayed gross motor development | 2014-06-06 | criteria provided, single submitter | clinical testing | |
| Centre for Mendelian Genomics, |
RCV001198404 | SCV001369331 | likely pathogenic | Charcot-Marie-Tooth disease axonal type 2O | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. |
| Ambry Genetics | RCV001267559 | SCV001445740 | pathogenic | Inborn genetic diseases | 2019-08-19 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV001198404 | SCV003442718 | pathogenic | Charcot-Marie-Tooth disease axonal type 2O | 2024-11-07 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 2332 of the DYNC1H1 protein (p.Arg2332Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant intellectual disability (PMID: 25590979, 27754416, 29286531). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 374190). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt DYNC1H1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
| Duke University Health System Sequencing Clinic, |
RCV003223402 | SCV003919013 | pathogenic | Intellectual disability, autosomal dominant 13 | 2023-04-20 | criteria provided, single submitter | research | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV003223402 | SCV005883666 | pathogenic | Intellectual disability, autosomal dominant 13 | 2024-12-12 | criteria provided, single submitter | clinical testing | Variant summary: DYNC1H1 c.6994C>T (p.Arg2332Cys) results in a non-conservative amino acid change located in the P-loop containing nucleoside triphosphate hydrolases (IPR027417) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. This variant was absent in gnomAD V4. c.6994C>T has been reported in the literature as a de novo occurrence in multiple individuals affected with Intellectual disability, autosomal dominant 13 (examples: Zhu_2015, Liu_2022, Internal data). These data indicate that the variant is likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 36175372, 25590979). ClinVar contains an entry for this variant (Variation ID: 374190). Based on the evidence outlined above, the variant was classified as pathogenic. |
| Inherited Neuropathy Consortium Ii, |
RCV001198404 | SCV004174362 | uncertain significance | Charcot-Marie-Tooth disease axonal type 2O | 2016-01-06 | no assertion criteria provided | literature only |